We are live on ! Find out more
HM

HealthCor Management Portfolio holdings

AUM $109M
1-Year Est. Return 10.64%
This Fund
S&P 500
This Quarter Est. Return
-8.51%
1 Year Est. Return
+10.64%
3 Year Est. Return
+50.22%
5 Year Est. Return
+140.3%
10 Year Est. Return
–
AUM
$995M
AUM Growth
-$504M
Cap. Flow
-$395M
Cap. Flow %
-39.65%
Top 10 Hldgs %
49.03%
Holding
79
New
15
Increased
11
Reduced
25
Closed
21

Top Buys

Rank Stock Value
1
HOLX
Hologic
HOLX
+$29.9M
2
CI icon
Cigna
CI
+$24.9M
3
LLY icon
Eli Lilly
LLY
+$21.2M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$18.3M
5
ISRG icon
Intuitive Surgical
ISRG
+$17M

Top Sells

Rank Stock Value
1
NVST icon
Envista
NVST
+$44.5M
2
ABBV icon
AbbVie
ABBV
+$41.2M
3
TFX icon
Teleflex
TFX
+$35.2M
4
ABT icon
Abbott
ABT
+$32.4M
5
CVS icon
CVS Health
CVS
+$29M

Sector Composition

Rank Sector Weight
1 Healthcare 93.68%
2 Financials 0.12%
3 Consumer Discretionary 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ITCI
51
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.54M 0.16%
27,070
+13,500
+99% +$765K
CYPH
52
Cypherpunk Technologies Inc
CYPH
$71.7M
$1.23M 0.12%
106,669
– –
IMA
53
ImageneBio Inc
IMA
$63.9M
$975K 0.1%
18,340
-5,628
-23% -$310K
EQRXW
54
DELISTED
EQRx, Inc. Warrant
EQRXW
$81K 0.01%
99,998
– –
LGV.WS
55
DELISTED
Longview Acquisition Corp. II Redeemable Warrants, each whole Warrant exercisable for one share of Class A Common Stock, each at an exercise price of $11.50 per share
LGV.WS
$56K 0.01%
427,178
– –
MSACW
56
DELISTED
Medicus Sciences Acquisition Corp. Warrant
MSACW
$15K ﹤0.01%
82,663
– –
OHPAW
57
DELISTED
Orion Acquisition Corp. Warrant
OHPAW
$12K ﹤0.01%
137,305
– –
EUCRW
58
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
$2K ﹤0.01%
78,059
– –
ABBV icon
59
AbbVie
ABBV
$431B
– –
-254,160
Closed -$41.2M
ALKS icon
60
Alkermes
ALKS
$8.11B
– –
-140,630
Closed -$3.7M
AMGN icon
61
Amgen
AMGN
$219B
– –
-108,890
Closed -$26.3M
CAH icon
62
Cardinal Health
CAH
$55.7B
– –
-317,280
Closed -$18M
CVS icon
63
CVS Health
CVS
$123B
– –
-286,600
Closed -$29M
HCA icon
64
HCA Healthcare
HCA
$88.5B
– –
-48,890
Closed -$12.3M
JAZZ icon
65
Jazz Pharmaceuticals
JAZZ
$16.7B
– –
-9,170
Closed -$1.43M
MRVI icon
66
Maravai LifeSciences
MRVI
$922M
– –
-200,000
Closed -$7.05M
NBIX icon
67
Neurocrine Biosciences
NBIX
$16.2B
– –
-23,480
Closed -$2.2M
NVST icon
68
Envista
NVST
$4.4B
– –
-914,490
Closed -$44.5M
PCRX icon
69
Pacira BioSciences
PCRX
$1.02B
– –
-13,930
Closed -$1.06M
PFE icon
70
Pfizer
PFE
$149B
– –
-242,880
Closed -$12.6M
PYXS icon
71
Pyxis Oncology
PYXS
$238M
– –
-217,457
Closed -$879K
REGN icon
72
Regeneron Pharmaceuticals
REGN
$79.5B
– –
-9,570
Closed -$6.68M
STXS icon
73
Stereotaxis
STXS
$135M
– –
-821,850
Closed -$3.07M
SYK icon
74
Stryker
SYK
$129B
– –
-43,760
Closed -$11.7M
TFX icon
75
Teleflex
TFX
$6.15B
– –
-99,150
Closed -$35.2M
1 2
3
4

Similar funds

IA
Integrity Advisory Overland Park, Kansas $109M AUM 15.71% 1-Year Est. Return
EPC
Emerson Point Capital Larchmont, New York $108M AUM 19.03% 1-Year Est. Return
TCMV
Technology Crossover Management VII Menlo Park, California $107M AUM 51.05% 1-Year Est. Return
SI
Salesforce Inc San Francisco, California $114M AUM 53.18% 1-Year Est. Return
HCWM
Harrison & Co Wealth Management Roanoke, Virginia $103M AUM 9.82% 1-Year Est. Return
PC
Phoenician Capital New York $117M AUM 9.46% 1-Year Est. Return
RF
Resolute Financial Newburyport, Massachusetts $118M AUM 11.75% 1-Year Est. Return
AWM
Align Wealth Management Oklahoma City, Oklahoma $118M AUM

HealthCor Management's Q2 2022 Portfolio in Review

As of Q2 2022, HealthCor Management held 79 positions worth $995M, down 34% from $1.5B the previous quarter. Its ten largest holdings account for 49% of the portfolio.

HealthCor Management withdrew a net $395M in Q2 2022, closing 21 positions and reducing 25 holdings. Its most notable exit was Envista, an estimated $44.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 94% of assets, up from 92% a quarter earlier, followed by Financials and Consumer Discretionary.

Against the trend, HealthCor Management opened a new position in Hologic worth $27.9M.

  • HealthCor Management's largest Q2 2022 buy was Hologic: 402,110 shares worth $27.9M.
  • HealthCor Management added most to Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2022, an estimated $18.3M increase.
  • HealthCor Management's biggest Q2 2022 reduction was Abbott, cutting an estimated $32.4M.
  • HealthCor Management fully exited Envista in Q2 2022, selling an estimated $44.5M.
  • HealthCor Management's ten largest holdings make up 49% of its $995M portfolio in Q2 2022.
  • HealthCor Management opened 15 new positions and closed 21 in Q2 2022.
  • HealthCor Management's portfolio value fell 34% quarter-over-quarter to $995M.

Based on HealthCor Management's 13F filing for Q2 2022, filed 15 Aug 2022.